Expression of TEIF protein in soft tissue tumors and its significance

Chinese Journal of Pathology

Volumn 35, Issue 11, 2006, Pages 651-655

  Gong, Yi Lei ^a   Li, Ting ^b   Guo, Hua ^b   Sun, Ying ^b   Chi, Ying Kai ^b   Ling, Yun ^b   Shen, Qi ^b   Liu, Hai Jing ^b   Hou, Lin ^b   Zhang, Bo ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NONE

Author keywords

Gene expression; Immunohistochemistry; Soft tissue neoplasms; Tissue array

Indexed keywords

DNA BINDING PROTEIN; POLYCLONAL ANTIBODY; TELOMERASE TRANSCRIPTIONAL ELEMENT INTERACTING FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; FIBROSARCOMA; HISTIOCYTOMA; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; NERVE SHEATH TUMOR; NEUROECTODERM TUMOR; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SARCOMA; SOFT TISSUE SARCOMA; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; FEMALE; HELA CELLS; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LEIOMYOMA; MALE; MIDDLE AGED; NEUROECTODERMAL TUMORS, PRIMITIVE; RHABDOMYOSARCOMA; SARCOMA; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 33846601331     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tang Z, Zhao Y, Mei F, et al. Molecular cloning and characterization of a human gene involved in transcriptional regulation of hTERT. Biochem Biophys Res Commun, 2004,324:1324-1333.
2. Chinese source
3. Mei F, Zhang B, Tang ZW, et al. Expression of a telomerase-associated gene in normal, atrophic, and tumorous testes. Chin Med Sci J, 2005, 20: 217-220.
4. Zhao Y, Zheng J, Ling Y, et al. Transcriptional upregulation of DNA polymerase β by TEIF. Biochem Biophys Res Commun, 2005, 333: 908-916.
5. Chinese source
6. Fletcher CD, Unni KK, Mertens F. Word Health Organization classification of tumours. Pathology and genetics of tumours of soft part tissue and bone. Lyon: IARC Press, 2002. 12-17.
7. Toffoli G, Doglioni C, Cernigoi C, et al. P53 overexpression in human soft tissue sarcomas: relation to biological aggressiveness. Ann Oncol, 1994,5:167-172.
8. Nilbert M, Meza-Zepeda LA, Francis P, et al. Lessons from genetic profiling in soft tissue sarcomas. Acta Orthop Scand Suppl, 2004, 75: 35-50.
9. Letson GD, Muro-Cacho CA. Genetic and molecular abnormalities in tumors of the bone and soft tissues. Cancer Control, 2001, 8: 239-251.
10. Umehara N, Ozaki T, Sugihara S, et al. Influence of telomerase activity on bone and soft tissue tumors. J Cancer Res Clin Oncol, 2004, 130: 411-416.
11. Tomoda R, Seto M, Tsumuki H, et al. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors. Cancer, 2002, 95; 1127-1133.
12. Yan P, Coindre JM, Benhattar J, et al. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. Cancer Res, 1999, 59: 3166-3170.
13. van Asseldonk M, Schepens M, de Bruijn D, et al. Construction of a 350-kb sequence-ready 11q13 cosmid contig encompassing the markers D11S4933 and D11S546: mapping of 11 genes and 3 tumor-associated translocation breakpoints. Genomics, 2000, 66; 35-42.
14. Zaharieva BM, Simon R, Diener PA, et al. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol, 2003, 201: 603-608.
15. Brown LA, Irving J, Parker R, et al. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Gynecol Oncol, 2006, 100: 264-270.